Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Salant

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2019
Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy?David J Salant
Nature Clinical Practice. Nephrology|October 24, 2007
Intravenous methylprednisolone or plasma exchange for adjunctive therapy of severe renal vasculitis?David J Salant
Seminars in Nephrology|October 29, 2013
Introduction: Complement-mediated kidney diseasesDavid J Salant
The New England Journal of Medicine|July 28, 2010
Goodpasture's disease--new secrets revealedDavid J Salant
Journal of the American Society of Nephrology : JASN|March 16, 2013
Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy?David J Salant
Journal of the American Society of Nephrology : JASN|September 25, 2015
Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?David J Salant
Journal of the American Society of Nephrology : JASN|December 4, 2010
Targeting complement C5 in atypical hemolytic uremic syndromeDavid J Salant
Nephron. Physiology|May 20, 2009
In search of the elusive membranous nephropathy antigenDavid J Salant
Current Opinion in Nephrology and Hypertension|November 20, 2018
Unmet challenges in membranous nephropathyDavid J Salant
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
An outline of essential topics in glomerular pathophysiology, diagnosis, and treatment for nephrology traineesSharon G Adler, David J Salant
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2019
Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy?David J Salant
Nature Clinical Practice. Nephrology|October 24, 2007
Intravenous methylprednisolone or plasma exchange for adjunctive therapy of severe renal vasculitis?David J Salant
Seminars in Nephrology|October 29, 2013
Introduction: Complement-mediated kidney diseasesDavid J Salant
The New England Journal of Medicine|July 28, 2010
Goodpasture's disease--new secrets revealedDavid J Salant
Journal of the American Society of Nephrology : JASN|March 16, 2013
Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy?David J Salant
Journal of the American Society of Nephrology : JASN|September 25, 2015
Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?David J Salant
Journal of the American Society of Nephrology : JASN|December 4, 2010
Targeting complement C5 in atypical hemolytic uremic syndromeDavid J Salant
Nephron. Physiology|May 20, 2009
In search of the elusive membranous nephropathy antigenDavid J Salant
Current Opinion in Nephrology and Hypertension|November 20, 2018
Unmet challenges in membranous nephropathyDavid J Salant
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
An outline of essential topics in glomerular pathophysiology, diagnosis, and treatment for nephrology traineesSharon G Adler, David J Salant
Pageof 9